Vitality Watch

Dossier rss news report 07-sep-2026
Press coverage of research or of a longevity trend

Mice With Growth Hormone Halted in Middle Age Live Longer

Key claim: An Aging Cell study reports that stopping growth hormone receptor production in middle-aged mice significantly extends their lifespan.

Abstract

Researchers publishing in Aging Cell have described how stopping growth hormone receptor production in midlife significantly lengthens the lives of mice. […]

Why this matters

Midlife-inducible GHR ablation extending mouse lifespan is the translationally relevant version of the classic congenital GHR/IGF-1 longevity phenotype — it tests whether the pathway can still be pulled after developmental windows close, which is the only version of the story that could plausibly map onto a human intervention. The underlying Aging Cell study is already logged in the GH/IGF-1 and mTOR pages; this news-report surfacing indicates the finding is entering the popular-longevity narrative, where the gap between a mouse GHR knockdown and any human GH-axis therapy (dwarfism trade-offs, cancer-risk balance, no human RCT) should be flagged whenever it is cited.

Source

Link

Briefing card

Mice With Growth Hormone Halted in Middle Age Live Longer
Stage: news report · rss · 07-sep-2026

An Aging Cell study reports that stopping growth hormone receptor production in middle-aged mice significantly extends their lifespan.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: url:https://lifespan.io/mice-with-growth-hormone-halted-in-middle-age-live-longer/

build build 880 · 2bcef25 · 2026-11-18